Cargando…
Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe
Objective To assess the association between pandemic influenza A (H1N1) 2009 vaccine and Guillain-Barré syndrome. Design Case-control study. Setting Five European countries. Participants 104 patients with Guillain-Barré syndrome and its variant Miller-Fisher syndrome matched to one or more controls....
Autores principales: | Dieleman, Jeanne, Romio, Silvana, Johansen, Kari, Weibel, Daniel, Bonhoeffer, Jan, Sturkenboom, Miriam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3134565/ https://www.ncbi.nlm.nih.gov/pubmed/21750072 http://dx.doi.org/10.1136/bmj.d3908 |
Ejemplares similares
-
Guillain-Barré Syndrome and Adjuvanted Pandemic Influenza A (H1N1) 2009 Vaccines: A Multinational Self-Controlled Case Series in Europe
por: Romio, Silvana, et al.
Publicado: (2014) -
Effectiveness of MF59™ Adjuvanted Influenza A(H1N1)pdm09 Vaccine in Risk Groups in the Netherlands
por: Wijnans, Leonoor, et al.
Publicado: (2013) -
Effectiveness of a MF-59™-adjuvanted pandemic influenza vaccine to prevent 2009 A/H1N1 influenza-related hospitalisation; a matched case-control study
por: Steens, Anneke, et al.
Publicado: (2011) -
Hospital Admissions, Transfers and Costs of Guillain-Barré Syndrome
por: van Leeuwen, Nikki, et al.
Publicado: (2016) -
Risk of Guillain–Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany†
por: Prestel, Jürgen, et al.
Publicado: (2014)